These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 9610944

  • 1. Corticotropin-releasing factor and defensive withdrawal: inhibition of monoamine oxidase prevents habituation to chronic stress.
    Ward HE, Johnson EA, Goodman IJ, Birkle DL, Cottrell DJ, Azzaro AJ.
    Pharmacol Biochem Behav; 1998 May; 60(1):209-15. PubMed ID: 9610944
    [Abstract] [Full Text] [Related]

  • 2. Effects of prenatal stress on defensive withdrawal behavior and corticotropin releasing factor systems in rat brain.
    Ward HE, Johnson EA, Salm AK, Birkle DL.
    Physiol Behav; 2000 May; 70(3-4):359-66. PubMed ID: 11006435
    [Abstract] [Full Text] [Related]

  • 3. Corticotropin-releasing factor antagonist attenuates the "anxiogenic-like" effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats.
    Basso AM, Spina M, Rivier J, Vale W, Koob GF.
    Psychopharmacology (Berl); 1999 Jul; 145(1):21-30. PubMed ID: 10445369
    [Abstract] [Full Text] [Related]

  • 4. Antagonism of CRF(2) receptors produces anxiolytic behavior in animal models of anxiety.
    Takahashi LK, Ho SP, Livanov V, Graciani N, Arneric SP.
    Brain Res; 2001 Jun 01; 902(2):135-42. PubMed ID: 11384606
    [Abstract] [Full Text] [Related]

  • 5. Chronic stimulation of corticotropin-releasing factor receptor 1 enhances the anxiogenic response of the cholecystokinin system.
    Sherrin T, Todorovic C, Zeyda T, Tan CH, Wong PT, Zhu YZ, Spiess J.
    Mol Psychiatry; 2009 Mar 01; 14(3):291-307. PubMed ID: 18195718
    [Abstract] [Full Text] [Related]

  • 6. Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats.
    Rodríguez de Fonseca F, Rubio P, Menzaghi F, Merlo-Pich E, Rivier J, Koob GF, Navarro M.
    J Pharmacol Exp Ther; 1996 Jan 01; 276(1):56-64. PubMed ID: 8558457
    [Abstract] [Full Text] [Related]

  • 7. Brain corticotropin-releasing factor mediates 'anxiety-like' behavior induced by cocaine withdrawal in rats.
    Sarnyai Z, Bíró E, Gardi J, Vecsernyés M, Julesz J, Telegdy G.
    Brain Res; 1995 Mar 27; 675(1-2):89-97. PubMed ID: 7796157
    [Abstract] [Full Text] [Related]

  • 8. Corticotropin-releasing factor (CRF) sensitization of ethanol withdrawal-induced anxiety-like behavior is brain site specific and mediated by CRF-1 receptors: relation to stress-induced sensitization.
    Huang MM, Overstreet DH, Knapp DJ, Angel R, Wills TA, Navarro M, Rivier J, Vale W, Breese GR.
    J Pharmacol Exp Ther; 2010 Jan 27; 332(1):298-307. PubMed ID: 19843974
    [Abstract] [Full Text] [Related]

  • 9. Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the rat.
    Spina MG, Merlo-Pich E, Akwa Y, Balducci C, Basso AM, Zorrilla EP, Britton KT, Rivier J, Vale WW, Koob GF.
    Psychopharmacology (Berl); 2002 Mar 27; 160(2):113-21. PubMed ID: 11875628
    [Abstract] [Full Text] [Related]

  • 10. Subtype-selective corticotropin-releasing factor receptor agonists exert contrasting, but not opposite, effects on anxiety-related behavior in rats.
    Zhao Y, Valdez GR, Fekete EM, Rivier JE, Vale WW, Rice KC, Weiss F, Zorrilla EP.
    J Pharmacol Exp Ther; 2007 Dec 27; 323(3):846-54. PubMed ID: 17855476
    [Abstract] [Full Text] [Related]

  • 11. Cocaine withdrawal enhances long-term potentiation induced by corticotropin-releasing factor at central amygdala glutamatergic synapses via CRF, NMDA receptors and PKA.
    Pollandt S, Liu J, Orozco-Cabal L, Grigoriadis DE, Vale WW, Gallagher JP, Shinnick-Gallagher P.
    Eur J Neurosci; 2006 Sep 27; 24(6):1733-43. PubMed ID: 17004937
    [Abstract] [Full Text] [Related]

  • 12. Astressin, a corticotropin releasing factor antagonist, reverses the anxiogenic effects of urocortin when administered into the basolateral amygdala.
    Sajdyk TJ, Gehlert DR.
    Brain Res; 2000 Sep 22; 877(2):226-34. PubMed ID: 10986336
    [Abstract] [Full Text] [Related]

  • 13. Corticotropin-releasing factor (CRF), but not corticosterone, increases basolateral amygdala CRF-binding protein.
    Herringa RJ, Mackenrodt DB, Barlow JD, Roseboom PH, Nanda SA, Kalin NH.
    Brain Res; 2006 Apr 14; 1083(1):21-8. PubMed ID: 16545343
    [Abstract] [Full Text] [Related]

  • 14. A study of the lasting effects of cocaine pre-exposure on anxiety-like behaviors under baseline conditions and in response to central injections of corticotropin-releasing factor.
    Erb S, Kayyali H, Romero K.
    Pharmacol Biochem Behav; 2006 Sep 14; 85(1):206-13. PubMed ID: 16987545
    [Abstract] [Full Text] [Related]

  • 15. Attenuation of stress-induced behavior by antagonism of corticotropin-releasing factor receptors in the central amygdala in the rat.
    Swiergiel AH, Takahashi LK, Kalin NH.
    Brain Res; 1993 Oct 01; 623(2):229-34. PubMed ID: 8221104
    [Abstract] [Full Text] [Related]

  • 16. The involvement of central noradrenergic systems and corticotropin-releasing factor in defensive-withdrawal behavior in rats.
    Yang XM, Gorman AL, Dunn AJ.
    J Pharmacol Exp Ther; 1990 Dec 01; 255(3):1064-70. PubMed ID: 2262892
    [Abstract] [Full Text] [Related]

  • 17. Behavioral and physiological consequences of repeated daily intracerebroventricular injection of corticotropin-releasing factor in the rat.
    Buwalda B, Van Kalkeren AA, de Boer SF, Koolhaas JM.
    Psychoneuroendocrinology; 1998 Apr 01; 23(3):205-18. PubMed ID: 9695127
    [Abstract] [Full Text] [Related]

  • 18. Effect of acupuncture on anxiety-like behavior during nicotine withdrawal and relevant mechanisms.
    Chae Y, Yeom M, Han JH, Park HJ, Hahm DH, Shim I, Lee HS, Lee H.
    Neurosci Lett; 2008 Jan 10; 430(2):98-102. PubMed ID: 18060697
    [Abstract] [Full Text] [Related]

  • 19. Local repeated corticotropin-releasing factor infusion exacerbates anxiety- and fear-related behavior: differential involvement of the basolateral amygdala and medial prefrontal cortex.
    Bijlsma EY, van Leeuwen ML, Westphal KG, Olivier B, Groenink L.
    Neuroscience; 2011 Jan 26; 173():82-92. PubMed ID: 21093544
    [Abstract] [Full Text] [Related]

  • 20. Antagonism of cannabinoid 1 receptors reverses the anxiety-like behavior induced by central injections of corticotropin-releasing factor and cocaine withdrawal.
    Kupferschmidt DA, Newman AE, Boonstra R, Erb S.
    Neuroscience; 2012 Mar 01; 204():125-33. PubMed ID: 21784132
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.